Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Jonathan A. Bernstein
Person

Jonathan A. Bernstein

Tracked across 1 events · 7 articles · First seen Mar 01, 2026 · Last active Mar 01, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Tech
Celldex Barzolvolimab Phase 2 Data Positive
Jonathan A. Bernstein, a trial investigator and Professor at the University of Cincinnati College of Medicine, presented the positive Phase 2 data for barzolvolimab. His involvement lends credibility to the study findings.
Mar 01, 2026 · 7 articles
NEWSDESK
Track Jonathan A. Bernstein live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.